5 Best Healthcare Stocks to Buy in 2023
Savings Corner
DECEMBER 24, 2023
The company is also developing drugs targeting other rare genetic diseases, as well as more common diseases, including type 1 diabetes. Novocure is evaluating the therapy in clinical studies targeting non-small cell lung cancer, ovarian cancer, brain metastases, and pancreatic cancer. Ideally, a company will already be profitable.
52 
Let's personalize your content